<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="82157">
  <stage>Registered</stage>
  <submitdate>15/09/2009</submitdate>
  <approvaldate>22/09/2009</approvaldate>
  <actrnumber>ACTRN12609000828224</actrnumber>
  <trial_identification>
    <studytitle>The use of bronchodilators in people with recently acquired spinal cord injury</studytitle>
    <scientifictitle>Effect of bronchodilators on respiratory function of people with recently acquired spinal cord injury</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>bronchodilators in acute sci</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>acute spinal cord injury and effects of bronchodilators on spirometry measures</healthcondition>
    <conditioncode>
      <conditioncode1>Respiratory</conditioncode1>
      <conditioncode2>Other respiratory disorders / diseases</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Respiratory</conditioncode1>
      <conditioncode2>Asthma</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Neurological</conditioncode1>
      <conditioncode2>Other neurological disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Subjects in the treatment group will receive 4 puffs of salbutamol (ventolin)via a spacer. Subjects in the control group will 4 puffs of placebo salbutamol administered in the same way. Both the salbutamol(ventolin) and placebo will be administered with subjects in lying using a fspacer Subjects will not be told whether they are receiving the experimental or sham condition .Within the next week experimental subjects will receive the placebo and control subjects will receive the salbutamol (ventolin) using the same procedure as outline above. In this way, subjects will act as their own controls.Minimum wash out period will be 48 hours.
Response to ventolin and placebo will be measured using spirometry and will be compared to a baseline measure of no intervention.</interventions>
    <comparator>placebo ventolin inhaler containing prolpellant only</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Change in Peak expiratory flow and Forced expiratory volume 1 and Forced Vital Capacity with salbutamol compared to placebo</outcome>
      <timepoint>10 minutes post treatment</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>spirometry (Peak expiratory flow and Forced expiratory volume 1 and Forced Vital Capacity )</outcome>
      <timepoint>spirometry 30 minutes post administration</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>response to ventolin and placebo over 30 minutes measured with spirometry. Patients will be required to perform a forced vital capacity manouvere in supine prior to and then at 10 minutes 30 minutes post administration of ventolin or placebo. Best of three attempts will be taken.</outcome>
      <timepoint>10 minutes and 1 hour post administration</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>People with tetraplegia or paraplegia above T4 acquired within 6 weeks of randomisation
Motor complete lesion (ie, American Spinal Injuries Association (ASIA)scale  A or B with no zones of partial motor preservation)
Able to provide informed consent
No recent pre morbid history of asthma or premorbid use of bronchodilators
not ventilated
 stable Vital capacity over preceeding 2 days OR stable respiratory status</inclusivecriteria>
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>No limit</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Not medically stable, requiring ventilatory support with mechanical ventilation via endothracheal tube or tracheostomy
Premorbid recent history of asthma or bronchodilator use</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>All patients with recently acquired Spinla Cord Injury admitted to the Royal North Shore Hospital will be screened for inclusion.The random allocation will be performed by a person independent to the study and stored off site in opaque sealed sequentially numbered envelopes</concealment>
    <sequence>Those eligible who provide consent will be randomly allocated to treatment or placebo group .Randomisation performed through random number allocation. Subjects will be allocated after collecting initial data.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Crossover</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>21/09/2009</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>20</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Royal North Shore Hospital Spinal Research Fund</primarysponsorname>
    <primarysponsoraddress>spinal injuries unit
Royal North Shore Hospital
pacific Hwy St Leonards
NSW 
2065</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname />
      <fundingaddress />
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>University</othercollaboratortype>
      <othercollaboratorname>University of Sydney</othercollaboratorname>
      <othercollaboratoraddress>University of Sydney
Sydney 
NSW Australia
2008</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Effect of ventolin vs placebo in acute tetraplegic patients. Spirometric outcome measures</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Northern sydney health Human research and Ethics committe</ethicname>
      <ethicaddress>Research Building
RNSH 
Pacific Hwy
St Leonards
2065</ethicaddress>
      <ethicapprovaldate>20/03/2008</ethicapprovaldate>
      <hrec>0807-140M</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Damien Barratt</name>
      <address>Physiotherapy dept
Spinal Injuries Unit
RNSH
Pacific Hwy
St Leonards NSW 2065</address>
      <phone>+612 8399 2102</phone>
      <fax />
      <email>dbarratt@naccahs.health.nsw.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Damien Barratt</name>
      <address>Physiotherapy dept
Spinal Injuries Unit
RNSH
Pacific Hwy
St Leonards NSW 2065</address>
      <phone>+612 8399 2102</phone>
      <fax />
      <email>dbarratt@naccahs.health.nsw.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Damien Barratt</name>
      <address>Physiotherapy dept
Spinal Injuries Unit
RNSH
Pacific Hwy
St Leonards NSW 2065</address>
      <phone>+61283992102</phone>
      <fax />
      <email>dbarratt@naccahs.health.nsw.gov.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>